MY101664A - Bbm-2478 antibiotic complex - Google Patents

Bbm-2478 antibiotic complex

Info

Publication number
MY101664A
MY101664A MYPI87002205A MYPI19872205A MY101664A MY 101664 A MY101664 A MY 101664A MY PI87002205 A MYPI87002205 A MY PI87002205A MY PI19872205 A MYPI19872205 A MY PI19872205A MY 101664 A MY101664 A MY 101664A
Authority
MY
Malaysia
Prior art keywords
bbm
antibiotic complex
complex
antibacterial
component
Prior art date
Application number
MYPI87002205A
Other languages
English (en)
Inventor
Sugawara Koko
Kawaguchi Hiroshi
Miyaki Takeo
Konishi Masataka
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MY101664A publication Critical patent/MY101664A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MYPI87002205A 1983-10-03 1987-09-29 Bbm-2478 antibiotic complex MY101664A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,453 US4518589A (en) 1983-10-03 1983-10-03 BBM-2478 Antibiotic complex

Publications (1)

Publication Number Publication Date
MY101664A true MY101664A (en) 1991-12-31

Family

ID=24146999

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002205A MY101664A (en) 1983-10-03 1987-09-29 Bbm-2478 antibiotic complex

Country Status (29)

Country Link
US (1) US4518589A (enExample)
JP (2) JPS60115599A (enExample)
AT (1) AT381507B (enExample)
AU (1) AU570271B2 (enExample)
BE (1) BE900735A (enExample)
CA (1) CA1242159A (enExample)
CH (1) CH666043A5 (enExample)
CY (1) CY1534A (enExample)
DE (1) DE3436137C2 (enExample)
DK (1) DK473484A (enExample)
ES (1) ES536455A0 (enExample)
FI (1) FI79141C (enExample)
FR (1) FR2555586B1 (enExample)
GB (1) GB2147582B (enExample)
GR (1) GR80551B (enExample)
HK (1) HK82790A (enExample)
HU (1) HU192461B (enExample)
IE (1) IE57825B1 (enExample)
IL (1) IL73126A (enExample)
IT (1) IT1176854B (enExample)
LU (1) LU85572A1 (enExample)
MX (1) MX9202848A (enExample)
MY (1) MY101664A (enExample)
NL (1) NL8403002A (enExample)
OA (1) OA07827A (enExample)
PT (1) PT79310B (enExample)
SE (1) SE460481B (enExample)
SU (1) SU1423001A3 (enExample)
ZA (1) ZA847723B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859598A (en) * 1984-03-26 1989-08-22 American Cyanamid Company Antibiotic LL-D42067β
US4626503A (en) * 1984-04-04 1986-12-02 American Cyanamid Company Antitumor agents LL-D49194α1, LL-D49194β1, LL-D49194β2, LL-D49194β3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω1, LL-D49194ω2, and LL-D49194ω3
NZ211872A (en) * 1984-04-27 1989-06-28 Ishihara Sangyo Kaisha Chartreusin derivatives and antitumorous compositions
ATE72447T1 (de) * 1985-10-23 1992-02-15 Ishihara Sangyo Kaisha Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
EP0381114B1 (en) * 1989-01-30 1994-09-28 Ishihara Sangyo Kaisha, Ltd. Exo-3',4'-0-benzylidene-3"-demethylchartreusin and its salts
IN172911B (enExample) * 1991-02-26 1994-01-01 Hoechst India
HU210418B (en) * 1991-05-30 1995-04-28 Bristol Myers Squibb Co Process for prepg. 2"-n-acyl derivs of elsamycin a and pharmaceutical compositions containing them
HU210499B (en) * 1991-05-30 1995-04-28 Bristol Myers Squibb Co Process for preparing 6-o-alkylelsamicin a deriv.s and pharmaceutical compn.s contg. them
ZA923815B (en) * 1991-05-30 1993-02-24 Bristol Myers Squibb Co Preparation of 6-o-acylelsamicin a derivatives
US5237055A (en) * 1991-05-30 1993-08-17 Bristol-Myers Squibb Company Chemical modification of 2"-amino group in elsamicin A
ZA923817B (en) * 1991-05-30 1993-02-24 Bristol Myers Squibb Co Chemical modification of elsamicin a at the 3'and/or 4'oh groups
US5229371A (en) * 1991-05-30 1993-07-20 Bristol-Myers Squibb Company Chemical modification of elsamicin A at the 3' and/or 4' OH groups
US5508268A (en) * 1993-08-12 1996-04-16 Bristol-Myers Squibb Parenteral elsamitrucin formulations
WO2008143677A1 (en) * 2007-05-24 2008-11-27 Spectrum Pharmaceuticals, Inc Stable solid elsamitrucin salts suitable for pharmaceutical formulations
US20080181971A1 (en) * 2007-01-25 2008-07-31 Guru Reddy Combination Cancer Treatments Comprising Elsamitrucin and Other Agents
BRPI0820811A2 (pt) * 2007-12-19 2018-03-27 Spectrum Pharmaceuticals Inc formulação de sal estável de elsamitrucina
JP2009207970A (ja) * 2008-03-03 2009-09-17 Marsima Aqua System Corp 空気揚水装置
CN111751469B (zh) * 2020-07-06 2022-06-14 江苏省中医院 一种液相色谱串联质谱测定血浆中教酒菌素浓度的方法

Also Published As

Publication number Publication date
ES8602135A1 (es) 1985-11-16
IE57825B1 (en) 1993-04-21
DK473484A (da) 1985-04-04
HK82790A (en) 1990-10-19
ZA847723B (en) 1985-05-29
OA07827A (fr) 1986-11-20
FI79141C (fi) 1989-11-10
NL8403002A (nl) 1985-05-01
JPH0641182A (ja) 1994-02-15
FI843823A0 (fi) 1984-09-28
GB8424810D0 (en) 1984-11-07
AT381507B (de) 1986-10-27
FR2555586B1 (fr) 1988-10-07
GR80551B (en) 1985-02-06
DE3436137C2 (de) 1993-12-02
IL73126A0 (en) 1984-12-31
IT8422961A0 (it) 1984-10-03
GB2147582B (en) 1987-04-15
IT8422961A1 (it) 1986-04-03
SE8404929L (sv) 1985-04-04
CH666043A5 (de) 1988-06-30
ES536455A0 (es) 1985-11-16
PT79310B (en) 1986-11-14
AU3354884A (en) 1986-09-11
CA1242159A (en) 1988-09-20
GB2147582A (en) 1985-05-15
IL73126A (en) 1989-05-15
PT79310A (en) 1984-11-01
LU85572A1 (fr) 1985-06-19
IE842511L (en) 1985-04-03
FI843823L (fi) 1985-04-04
JPH0689017B2 (ja) 1994-11-09
MX9202848A (es) 1992-06-30
FR2555586A1 (fr) 1985-05-31
SE460481B (sv) 1989-10-16
ATA313184A (de) 1986-03-15
SE8404929D0 (sv) 1984-10-02
DK473484D0 (da) 1984-10-02
BE900735A (fr) 1985-04-02
FI79141B (fi) 1989-07-31
HUT37170A (en) 1985-11-28
AU570271B2 (en) 1988-03-10
CY1534A (en) 1990-11-16
DE3436137A1 (de) 1985-05-15
HU192461B (en) 1987-06-29
SU1423001A3 (ru) 1988-09-07
JPH0566394B2 (enExample) 1993-09-21
JPS60115599A (ja) 1985-06-22
IT1176854B (it) 1987-08-18
US4518589A (en) 1985-05-21

Similar Documents

Publication Publication Date Title
HK82790A (en) Bbm-2478 antibiotic complex
AU3408693A (en) An elastomeric metallized fabric and process to make the same
AU568160B2 (en) Split screen smooth scrolling arrangement
AU7111091A (en) Process for production of b avermectins and cultures therefor
AU565019B2 (en) Cl-1557 antibiotic/antitumor compounds
IE782078L (en) Deoxynarasin antibiotics
AU617059B2 (en) Monosulfactams
AU589918B2 (en) Antitumor antibiotics (LL-E33288 complex)
MY104032A (en) Bu-3420t antitumor antibiotic.
EP0161849A3 (en) Cl-1724 antibiotic-antitumour compounds, pharmaceutical compositions comprising the compounds and a novel microorganism for producing the compounds
SE8402619D0 (sv) Bbm-1675, a new antitumor antibiotic complex
AU598531B2 (en) Antibiotic A42125 and process for its production
NZ184142A (en) Antibiotics of a-35512 group from culturing streptomyces candidus nrrl 8156
EP0255299A3 (en) Glycopeptide antibiotics
AU5576680A (en) Assembly of furniture
AU4709485A (en) Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
YU198888A (en) Process for obtaining ether's polycyclical antibiotic
AU592862B2 (en) Yeast production of streptolinase
AU7581587A (en) Improving immunity to channel distortion of F.M. video signals
IE46064L (en) Antibiotic c-15003
MY129978A (en) New antitumor antibiotic
NZ180300A (en) Antibiotic 32,999 rp produced by microbiological reduction and by cultivation of streptomyces coeruleorubidus(nrrl 3046,nrrl o045nrrl 8098)strepthomyces bifurcus(nrrl3539)andstreptomyces atroviolaceus(nrrl 8148)
GB8407990D0 (en) Macrole antibiotics
AU2096588A (en) Antibiotic A80577 and process for its production
NZ219246A (en) Antibiotic mixture prepared by fermentation of streptomyces sp